An update on oral contraceptive options.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2004 AND VI 39 AND IP 2
Results: 23
1
2
Memantine: an oral NMDA antagonist for the treatment of moderate-to-severe Alzheimer's disease.
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
3
News capsules. Extended-release formulation of oxymorphone effective for pain relief in osteoarthritis.
- Published in:
- 2004
- Publication type:
- Journal Article
4
News capsules. Special report: ACR coverage: etanercept demonstrates significant remission data as combination rheumatoid arthritis therapy.
- Published in:
- 2004
- Publication type:
- Journal Article
5
Drug Watch.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 124
- Publication type:
- Article
6
Drug pricing promises to be a much-debated issue in 2004.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 122
- By:
- Publication type:
- Article
7
An update on oral contraceptive options.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 104
- By:
- Publication type:
- Article
8
Memantine.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 91
- By:
- Publication type:
- Article
9
Safety labeling updates & new warnings.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 90
- Publication type:
- Article
10
FDA investigating reports of unlicensed influenza vaccine.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 90
- Publication type:
- Article
11
Antiretroviral drugs linked to higher MI risk.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 90
- Publication type:
- Article
12
Updated Beers criteria point out medications dangerous to elderly.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 89
- Publication type:
- Article
13
FDA actions in brief.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 80
- Publication type:
- Article
14
First-time generic approvals.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 80
- Publication type:
- Article
15
Pipeline preview.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 79
- Publication type:
- Article
16
Lexapro.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 79
- Publication type:
- Article
17
Symbyax.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 79
- Publication type:
- Article
18
Drug and Formulary Trends.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 78
- Publication type:
- Article
19
Eye on the Literature.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 76
- Publication type:
- Article
20
Extended-release formulation of oxymorphone effective for pain relief in osteoarthritis.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 75
- Publication type:
- Article
21
Rituximab mono/combo therapies show promise for severe rheumatoid arthritis.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 74
- Publication type:
- Article
22
Etanercept efficacy for psoriatic arthritis sustained at 2 years.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 74
- Publication type:
- Article
23
Etanercept demonstrates significant remission data as combination rheumatoid arthritis therapy.
- Published in:
- Formulary, 2004, v. 39, n. 2, p. 64
- Publication type:
- Article